Dashboard: Filter Bricks

Main page content

Displaying results 1 - 7 of 7
Publication ID: PEP19-02-01-003
Published:

This updated TIP includes the latest evidence on motivation-enhancing approaches and strategies. It describes how substance use disorder treatment providers can use these approaches and strategies to increase participation and retention in substance use disorder treatment.

Publication ID: SMA15-4442
Published:

This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

Publication ID: SMA14-4853
Published:

This comic book presents basic information about hepatitis C for people living with mental illness or substance use disorders. It uses plain language and a simple cartoon style to explain what hepatitis C is, how to avoid it, the screening process, and treatment options.

Publication ID: SMA14-4844
Published:

This guide provides practical information to clinicians and other professional care providers who treat women living with substance use disorders. It addresses risk factors, mental illness and substance use screening, patient assessment, treatment, and relapse.

Publication ID: SMA14-4736
Published:

This guide addresses specific treatment needs of adult men living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of substance use among men and specific treatment issues and strategies.

Publication ID: SMA13-4789
Published:

This quick guide helps clinicians address the specific needs of women living with substance use disorders. It reviews gender-specific research and best practices—such as common patterns of misuse—and specific screening and treatment strategies.

Publication ID: SMA12-4688
Published:

This manual offers guidelines for medication-assisted treatment for people, particularly veterans, living with post-traumatic stress disorder and co-occurring opioid use disorders. It covers screening, concomitant treatment, pharmacotherapy, and multiple misused substances.